Page2RRS

• 23 Oct 2009 19:39

  23/10/09	Press Release - Arpida A/S withdraws its marketing authorisation application for Mersarex (iclaprim)	Press Office
  23/10/09	Monthly report from the PDCO October meeting	Press Office
  23/10/09	CHMP revised EPAR on: RebetolINN: ribavirinRev. 18	EPARs
  23/10/09	CVMP revised EPAR on: Nobilis Influenza H5N2Rev. 4	Veterinary Medicines	EPARs
  23/10/09	Concept paper on revision of Chapter 7 of the GMP Guide concerning "outsourced GMP activities"	Inspections	Good Manufacturing Practice
  23/10/09	Press Release from the CHMP October meeting	Press Office
  23/10/09	Updated temporary treatment recommendations for Cerezyme	Human Medicines	EPARs
  23/10/09	CHMP summaries of positive opinion for: - Sildenafil ratiopharmINN: sildenafil - ZenasINN: amifampridine - ScintimunINN: besilesomab - Leflunomide WinthropINN: leflunomide	Human Medicines	Summay of Opinion
  23/10/09	CHMP post-authorisation summary of positive opinion for: - XeristarINN: duloxetine hydrochloride - PritorINN: telmisartan - KinzalmonoINN: telmisartan - MicardisINN: telmisartan - AdcircaINN: tadalafil - CymbaltaINN: duloxetine hydrochloride - AngioxNN: bivalirudin	Human Medicines	Summay of Opinion
  23/10/09	CHMP Opinions on Referrals: - Q&A on the referral for Teicoplanin Hospira powder and solvent for injection containing 200 or 400 mg teicoplanin - Q&A on the referral for Myderison tablets containing tolperisone hydrochloride 50 and 150 mg - Q&A on the withdrawal of the marketing authorisation for medicines containing dextropropoxyphene	Human Medicines	Referrals - Referral Opinions
  Updated public summary of positive opinion for orphan designation of: -	Human Medicines

  23 October, 2009

  Permalink  |  View Entire Page

Search the Site

Custom Search